Search | Page 12 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. What is Secondary MDS? Everything You Need to Know

    ... who have been previously treated for cancer with chemotherapy or radiation therapy. In this webinar, Dr. Walker ...

    LMS Item last updated 06/10/2016 - 1:24pm.

  2. What is Secondary MDS? Everything You Need to Know

    ... who have been previously treated for cancer with chemotherapy or radiation therapy. During this recorded program on May ...

    LMS Item last updated 06/10/2016 - 1:24pm.

  3. MDS Progression to AML: What Patients Need to Know

    ... myeloid leukemia (AML), which does not respond well to chemotherapy . AML is a bone marrow malignancy where the marrow is ...

    LMS Item last updated 06/10/2016 - 1:24pm.

  4. MDS Progression to AML: What Patients Need to Know

    ... myeloid leukemia (AML), which does not respond well to chemotherapy . AML is a bone marrow malignancy where the marrow is ...

    LMS Item last updated 06/10/2016 - 1:24pm.

  5. Study of Palifermin (Kepivance) in Persons Undergoing Unrelated Donor Allogeneic Hematopoietic Cell Transplantation

    ... - To see if high doses of palifermin before chemotherapy are safe, prevent chronic GVHD, and improve immune function ... catheter if they do not have one. Have 1 3 rounds of chemotherapy. Take more tests to make sure they can have the transplant, ...

    Clinical Trial last updated 04/29/2016 - 1:00pm.

  6. Study of FF-10501-01 in Patients With Relapsed or Refractory Hematological Malignancies

    ... therapies At least 3 weeks beyond the last chemotherapy , targeted anticancer agent, major surgery or experimental ...

    Clinical Trial last updated 06/06/2016 - 10:47am.

  7. Lenalidomide and Rituximab in Subjects With Previously Untreated Indolent Non-Hodgkin's Lymphoma

    ... is effective as a single agent and in combination with chemotherapy for indolent Non-Hodgkin's Lymphoma. The purpose of this ...

    Clinical Trial last updated 06/06/2016 - 10:17am.

  8. An Open-label Study of Lirilumab (BMS-986015) in Combination With 5-azacytidine (Vidaza) for the Treatment of Patients With Refractory/ Relapsed Acute Myeloid Leukemia

    ... be used for AML. Prior therapy with hydroxyurea, chemotherapy , biological or targeted therapy (e.g. FLT3 inhibitors, other ...

    Clinical Trial last updated 06/06/2016 - 1:26pm.

  9. Intra-Osseous Co-Transplant of UCB and hMSC

    ... with hematologic malignancies. Giving low doses of chemotherapy and total-body irradiation before a co-transplant of donor ... by flow cytometry after 2 or more cycles of chemotherapy No complete remission (CR) within 4 weeks of initial ...

    Clinical Trial last updated 05/02/2016 - 11:15am.

  10. Biting into the Elephant

    ... medication during my pre-bone marrow transplant chemotherapy regimen. There, hanging on the pole, was the bag marked ...

    Patient Chronicle last updated 06/27/2016 - 2:22pm.